What Wellington Management Group LLP changed, 2013 to 2026
53 quarterly 13F filings, from Q2 2013 to Q2 2026, each read from the filing itself. A quarter is compared only with the quarter before it, so a quarter with no filing is a gap in the record, not a sale.
Reported book
$580bn
$306bn at Q2 2013
Positions
1,921
2,125 at Q2 2013
Top ten weight
25%
15% at Q2 2013
Typical quarterly turnover
about 8%
Estimated from share changes
- Q2 2013: $306bn
- Q3 2013: $319bn
- Q4 2013: $348bn
- Q1 2014: $360bn
- Q2 2014: $372bn
- Q3 2014: $363bn
- Q4 2014: $378bn
- Q1 2015: $389bn
- Q2 2015: $388bn
- Q3 2015: $359bn
- Q4 2015: $382bn
- Q1 2016: $380bn
- Q2 2016: $387bn
- Q3 2016: $399bn
- Q4 2016: $399bn
- Q1 2017: $415bn
- Q2 2017: $425bn
- Q3 2017: $436bn
- Q4 2017: $453bn
- Q1 2018: $442bn
- Q2 2018: $449bn
- Q3 2018: $475bn
- Q4 2018: $400bn
- Q1 2019: $442bn
- Q2 2019: $452bn
- Q3 2019: $443bn
- Q4 2019: $477bn
- Q1 2020: $378bn
- Q2 2020: $449bn
- Q3 2020: $483bn
- Q4 2020: $543bn
- Q1 2021: $568bn
- Q2 2021: $601bn
- Q3 2021: $588bn
- Q4 2021: $625bn
- Q1 2022: $584bn
- Q2 2022: $497bn
- Q3 2022: $469bn
- Q4 2022: $499bn
- Q1 2023: $505bn
- Q2 2023: $527bn
- Q3 2023: $500bn
- Q4 2023: $536bn
- Q1 2024: $564bn
- Q2 2024: $560bn
- Q3 2024: $571bn
- Q4 2024: $546bn
- Q1 2025: $520bn
- Q2 2025: $551bn
- Q3 2025: $571bn
- Q4 2025: $571bn
- Q1 2026: $535bn
- Q2 2026: $580bn
- Q2 2013: 15%
- Q3 2013: 14%
- Q4 2013: 14%
- Q1 2014: 15%
- Q2 2014: 15%
- Q3 2014: 17%
- Q4 2014: 16%
- Q1 2015: 17%
- Q2 2015: 17%
- Q3 2015: 16%
- Q4 2015: 17%
- Q1 2016: 17%
- Q2 2016: 17%
- Q3 2016: 16%
- Q4 2016: 15%
- Q1 2017: 15%
- Q2 2017: 14%
- Q3 2017: 14%
- Q4 2017: 14%
- Q1 2018: 14%
- Q2 2018: 14%
- Q3 2018: 15%
- Q4 2018: 16%
- Q1 2019: 14%
- Q2 2019: 15%
- Q3 2019: 15%
- Q4 2019: 16%
- Q1 2020: 17%
- Q2 2020: 18%
- Q3 2020: 18%
- Q4 2020: 17%
- Q1 2021: 17%
- Q2 2021: 17%
- Q3 2021: 17%
- Q4 2021: 18%
- Q1 2022: 18%
- Q2 2022: 18%
- Q3 2022: 18%
- Q4 2022: 17%
- Q1 2023: 18%
- Q2 2023: 20%
- Q3 2023: 20%
- Q4 2023: 20%
- Q1 2024: 21%
- Q2 2024: 24%
- Q3 2024: 23%
- Q4 2024: 25%
- Q1 2025: 23%
- Q2 2025: 25%
- Q3 2025: 27%
- Q4 2025: 28%
- Q1 2026: 26%
- Q2 2026: 25%
The positions that defined it
Every position that was ever among the 25 largest: when it first appeared, when it was largest, and where it stands in Q2 2026. The line is its reported value each quarter.
| Position | Value over time | First listed | Largest | Q2 2026 |
|---|---|---|---|---|
| Nvidia Corp(NVDA) | Q1 2017 | $26.8bnQ3 2025 | $24.4bn | |
| Broadcom Inc(AVGO) | Q2 2018 | $19.5bnQ2 2026 | $19.5bn | |
| Microsoft Corp(MSFT) | Q2 2013 | $26.7bnQ3 2025 | $17.8bn | |
| Apple Inc(AAPL) | Q2 2013 | $22.5bnQ3 2024 | $17.2bn | |
| Alphabet Inc(GOOGL)Capital Stock Class A | Q4 2015 | $17.9bnQ4 2025 | $15.9bn | |
| Lilly Eli & Co(LLY) | Q2 2013 | $14.4bnQ4 2025 | $13.2bn | |
| Amazon Com Inc(AMZN) | Q2 2013 | $15.3bnQ4 2025 | $13.1bn | |
| Merck & Co Inc New(MRK) | Q2 2013 | $11.4bnQ1 2024 | $11.1bn | |
| Mastercard Inc(MA)Class A | Q2 2013 | $7.7bnQ4 2025 | $6.5bn | |
| Alphabet Inc(GOOG)Capital Stock Class C | Q4 2015 | $6.1bnQ2 2026 | $6.1bn | |
| Micron Technologyinc(MU) | Q2 2013 | $5.8bnQ2 2026 | $5.8bn | |
| Johnson & Johnson(JNJ) | Q2 2013 | $5.8bnQ1 2022 | $5.7bn | |
| Verizon Communications Inc(VZ) | Q2 2013 | $7.1bnQ1 2019 | Below the listed rangelast listed Q1 2025 | |
| Allergan PLC | Q2 2015 | $6.6bnQ4 2015 | Soldlast listed Q1 2020 | |
| Comcast Corp New(CMCSA)Class A | Q2 2013 | $6.4bnQ4 2020 | Below the listed rangelast listed Q3 2024 | |
| Actavis PLC | Q4 2013 | $5.3bnQ1 2015 | Soldlast listed Q1 2015 | |
| PNC Finl SVCS Group Inc(PNC) | Q2 2013 | $5.0bnQ4 2017 | Below the listed rangelast listed Q4 2025 | |
| Honeywell Intl Inc(HON) | Q2 2013 | $4.6bnQ4 2022 | Soldlast listed Q1 2026 | |
| Accenture PLC Ireland(ACN)Shares Class A | Q2 2013 | $4.6bnQ4 2021 | Below the listed rangelast listed Q1 2026 | |
| Intuit(INTU) | Q3 2013 | $4.6bnQ2 2025 | Below the listed rangelast listed Q1 2026 |
Quarter by quarter
Q2 2019: $452bn across 2,039 positions
Against Q1 2019: 190 new, 826 added to, 928 trimmed, 171 sold out, across all 2,039 positions.
Turnover about 7% of the book, estimated from share changes at quarter-end prices.
Largest additions
- Pfizer Inc (PFE)+$2.6bn
- Bank of America Corporation (BAC)+$965m
- Coca Cola Co (KO)+$891m
- Home Depot Inc (HD)+$771m
- JPMorgan Chase & Co (JPM)+$734m
- Facebook Inc (META)+$669m
- Medtronic PLC (MDT)+$647m
- Marvell Technology Group LTD+$630m
Largest reductions
- Lilly Eli & Co (LLY)-$1.2bn
- Wells Fargo & Co New (WFC)-$1.1bn
- Alibaba Group HLDG LTD (BABA)-$862m
- Bristol Myers Squibb Co (BMY)-$838m
- 3M Co (MMM)-$751m
- Occidental Pete Corp Del (OXY)-$698m
- Qualcomm Inc (QCOM)-$630m
- Merck & Co Inc New (MRK)-$592m
Opened
Nothing new among the largest positions.
Sold out
- Dowdupont Incwas $2.1bn
- Transcanada Corpwas $1.4bn
- Zillow Group Inc (Z)was $189m
- Union Bankshares Corp Newwas $145m
- Universal Displaycorp (OLED)was $112m
- Tenneco Incwas $70m
- Ambarellainc (AMBA)was $47m
- Noah HLDGS LTD (NOAH)was $44m
Largest positions, Q2 2019
The largest 25 of 2,039 reported positions; the largest 500 carry 92.3% of the reported value.
| Position | Value | Weight | On the quarter |
|---|---|---|---|
| Microsoft Corp (MSFT) | $10.3bn | 2.3% | Trimmed |
| Unitedhealth Group Inc (UNH) | $7.6bn | 1.7% | Added |
| Medtronic PLC (MDT) | $6.9bn | 1.5% | Added |
| Verizon Communications Inc (VZ) | $6.8bn | 1.5% | Trimmed |
| Bank of America Corporation (BAC) | $6.8bn | 1.5% | Added |
| JPMorgan Chase & Co (JPM) | $6.4bn | 1.4% | Added |
| Pfizer Inc (PFE) | $5.8bn | 1.3% | Added |
| Amazon Com Inc (AMZN) | $5.3bn | 1.2% | Added |
| Comcast Corp New (CMCSA) | $5.2bn | 1.2% | Added |
| Bristol Myers Squibb Co (BMY) | $5.2bn | 1.1% | Trimmed |
| Chevron Corp New (CVX) | $5.1bn | 1.1% | Added |
| American Tower Corp New (AMT) | $4.9bn | 1.1% | Trimmed |
| Coca Cola Co (KO) | $4.7bn | 1.0% | Added |
| Merck & Co Inc New (MRK) | $4.6bn | 1.0% | Trimmed |
| Lockheed Martin Corp (LMT) | $4.6bn | 1.0% | Trimmed |
| Chubb Limited (CB) | $4.4bn | 1.0% | Trimmed |
| Alphabet Inc (GOOGL) | $4.3bn | 0.9% | Added |
| Home Depot Inc (HD) | $4.1bn | 0.9% | Added |
| Exxon Mobil Corp (XOM) | $4.1bn | 0.9% | Added |
| Allergan PLC | $3.8bn | 0.8% | Trimmed |
| PNC Finl SVCS Group Inc (PNC) | $3.7bn | 0.8% | Trimmed |
| Abbott Labs (ABT) | $3.7bn | 0.8% | Trimmed |
| Pepsico Inc (PEP) | $3.7bn | 0.8% | Trimmed |
| Cisco Sys Inc (CSCO) | $3.7bn | 0.8% | Trimmed |
| Lilly Eli & Co (LLY) | $3.5bn | 0.8% | Trimmed |
The books most like this one
Among the managers whose filings are on file, at Q2 2026. Overlap is the share of the two books that is the same: for every stock both list, the smaller of its two weights, added up. Two books can overlap because both own the largest companies; it says nothing about whether the managers agree.
| Manager | Overlap | Stocks in both | Overlap over time | |
|---|---|---|---|---|
| T. Rowe Price Associates Inc | at least 54% | 282 | Compare | |
| Fidelity (FMR LLC) | at least 48% | 250 | Compare | |
| Invesco Ltd | at least 47% | 269 | Compare | |
| MFS Investment Management | at least 47% | 247 | Compare | |
| Janus Henderson Group Ltd | at least 46% | 222 | Compare | |
| AllianceBernstein LP | at least 46% | 243 | Compare | |
| Neuberger Berman Group LLC | at least 46% | 225 | Compare | |
| Capital Research Global Investors | at least 43% | 189 | Compare |
“At least” where either manager has more positions than are read each quarter: a stock both hold below that range is not counted.
The filings behind it
Every quarter above is one 13F holdings report, with any amendment the filer made to it applied in the order it was filed. Where the reporting entity changed, each quarter keeps the filer that actually reported it.
| Quarter | Filer | Book | Amended | Filing |
|---|---|---|---|---|
| Q2 2026 | Wellington Management Group LLP | $580bn | 13F-HR | |
| Q1 2026 | Wellington Management Group LLP | $535bn | 13F-HR | |
| Q4 2025 | Wellington Management Group LLP | $571bn | 13F-HR | |
| Q3 2025 | Wellington Management Group LLP | $571bn | 13F-HR | |
| Q2 2025 | Wellington Management Group LLP | $551bn | 13F-HR | |
| Q1 2025 | Wellington Management Group LLP | $520bn | 13F-HR | |
| Q4 2024 | Wellington Management Group LLP | $546bn | 1 | 13F-HR |
| Q3 2024 | Wellington Management Group LLP | $571bn | 13F-HR | |
| Q2 2024 | Wellington Management Group LLP | $560bn | 13F-HR | |
| Q1 2024 | Wellington Management Group LLP | $564bn | 13F-HR | |
| Q4 2023 | Wellington Management Group LLP | $536bn | 1 | 13F-HR |
| Q3 2023 | Wellington Management Group LLP | $500bn | 1 | 13F-HR |
| Q2 2023 | Wellington Management Group LLP | $527bn | 13F-HR | |
| Q1 2023 | Wellington Management Group LLP | $505bn | 13F-HR | |
| Q4 2022 | Wellington Management Group LLP | $499bn | 13F-HR | |
| Q3 2022 | Wellington Management Group LLP | $469bn | 13F-HR | |
| Q2 2022 | Wellington Management Group LLP | $497bn | 13F-HR | |
| Q1 2022 | Wellington Management Group LLP | $584bn | 13F-HR | |
| Q4 2021 | Wellington Management Group LLP | $625bn | 13F-HR | |
| Q3 2021 | Wellington Management Group LLP | $588bn | 13F-HR | |
| Q2 2021 | Wellington Management Group LLP | $601bn | 13F-HR | |
| Q1 2021 | Wellington Management Group LLP | $568bn | 13F-HR | |
| Q4 2020 | Wellington Management Group LLP | $543bn | 13F-HR | |
| Q3 2020 | Wellington Management Group LLP | $483bn | 13F-HR | |
| Q2 2020 | Wellington Management Group LLP | $449bn | 13F-HR | |
| Q1 2020 | Wellington Management Group LLP | $378bn | 13F-HR | |
| Q4 2019 | Wellington Management Group LLP | $477bn | 13F-HR | |
| Q3 2019 | Wellington Management Group LLP | $443bn | 13F-HR | |
| Q2 2019 | Wellington Management Group LLP | $452bn | 13F-HR | |
| Q1 2019 | Wellington Management Group LLP | $442bn | 13F-HR | |
| Q4 2018 | Wellington Management Group LLP | $400bn | 13F-HR | |
| Q3 2018 | Wellington Management Group LLP | $475bn | 13F-HR | |
| Q2 2018 | Wellington Management Group LLP | $449bn | 13F-HR | |
| Q1 2018 | Wellington Management Group LLP | $442bn | 13F-HR | |
| Q4 2017 | Wellington Management Group LLP | $453bn | 13F-HR | |
| Q3 2017 | Wellington Management Group LLP | $436bn | 13F-HR | |
| Q2 2017 | Wellington Management Group LLP | $425bn | 13F-HR | |
| Q1 2017 | Wellington Management Group LLP | $415bn | 13F-HR | |
| Q4 2016 | Wellington Management Group LLP | $399bn | 13F-HR | |
| Q3 2016 | Wellington Management Group LLP | $399bn | 13F-HR | |
| Q2 2016 | Wellington Management Group LLP | $387bn | 13F-HR | |
| Q1 2016 | Wellington Management Group LLP | $380bn | 13F-HR | |
| Q4 2015 | Wellington Management Group LLP | $382bn | 13F-HR | |
| Q3 2015 | Wellington Management Group LLP | $359bn | 13F-HR | |
| Q2 2015 | Wellington Management Group LLP | $388bn | 13F-HR | |
| Q1 2015 | Wellington Management Group LLP | $389bn | 13F-HR | |
| Q4 2014 | Wellington Management Group LLP | $378bn | 13F-HR | |
| Q3 2014 | Wellington Management Group LLP | $363bn | 13F-HR | |
| Q2 2014 | Wellington Management Group LLP | $372bn | 13F-HR | |
| Q1 2014 | Wellington Management Group LLP | $360bn | 13F-HR | |
| Q4 2013 | Wellington Management Group LLP | $348bn | 13F-HR | |
| Q3 2013 | Wellington Management Group LLP | $319bn | 13F-HR | |
| Q2 2013 | Wellington Management Group LLP | $306bn | 13F-HR |
Reading this record
A 13F lists US-listed long equity and options at the quarter end, filed up to 45 days later. It shows what was held, not when it was bought or at what price, and nothing short. Where a quarter lists only the largest positions, a name missing from it may still be held below that range; the counts of what was opened and sold always cover the whole filing.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More